Crossmark

Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship

Crossref DOI link: https://doi.org/10.1186/s13756-019-0496-4

Published Online: 2019-03-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Heard, Katie L.

Hughes, Stephen

Mughal, Nabeela

Azadian, Berge S.

Moore, Luke S. P.
License Information

Text and Data Mining valid from 2019-03-06
More Information

Article History

Received: 29 August 2018

Accepted: 13 February 2019

First Online: 6 March 2019

Ethics approval and consent to participate

: Approval was gained for this project as a service evaluation from the Joint Research Compliance Office, Chelsea & Westminster Hospital Campus, Imperial College London (ref: CAPP 1327, July 2015). Data was collected as routine and no patient level data was used.

: No patient identifiable data necessitating consent was used in this study.

: LSPM has consulted for bioMerieux (2013), DNAelectronics (2015), Dairy Crest (2017–2018), received speaker fees from Profile Pharma (2018) and Pfizer (2018), received research grants from the National Institute for Health Research (2013–2018) and Leo Pharma (2016), and received educational support from Eumedica (2016–2017). NM has consulted for Beyer (2016) and received educational support from Eumedica (2016) and Baxter (2017). SH has received educational support from Baxter (2017). All other authors have no conflicts of interest to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.